Papers - MIZOGUCHI, Hiroyuki
-
Matrix metalloproteinase-9 contributes to kindled seizure development in pentylenetetrazole-treated mice by converting pro-BDNF to mature BDNF in the hippocampus. Reviewed
Mizoguchi H, Nakade J, Tachibana M, Ibi D, Someya E, Koike H, Kamei H, Nabeshima T, Itohara S, Takuma K, Sawada M, Sato J, Yamada K.
J Neurosci. Vol. 31 ( 36 ) page： 12963-12971 2011.9
-
Nicotine ameliorates impairment of working memory in methamphetamine-treated rats. Reviewed
Mizoguchi H, Ibi D, Takase F, Nagai T, Kamei H, Toth E, Sato J, Takuma K, Yamada K.
Behav Brain Res. Vol. 220 ( 1 ) page： 159-163 2011.6
-
Lowering barometric pressure aggravates depression-like behavior in rats. Reviewed
Mizoguchi H, Fukaya K, Mori R, Itoh M, Funakubo M, Sato J.
Behav Brain Res. Vol. 218 page： 190-193 2011.3
-
Pharmacologic treatment with GABAB receptor agonist of methamphetamine-induced cognitive impairment in mice.BBB Reviewed
Mizoguchi H, Yamada K.
Current Neuropharmacol. Vol. 9 ( 1 ) page： 109-112 2011.3
-
Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage. Reviewed
Shichi K, Fujita-Hamabe W, Harada S, Mizoguchi H, Yamada K, Nabeshima T, Tokuyama S.
J Pharmacol Exp Ther. page： in press 2011
-
Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease. Reviewed
Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, Liang J, Li H, Zhou Y, Mori R, Yasuoka S, Li E, Parajuli B, Kawanokuchi J, Sonobe Y, Sato J, Yamanaka K, Sobue G, Mizuno T, Suzumura A.
PLoS One. Vol. 6 ( 6 ) page： e21108 2011
-
Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy.
Mizoguchi H, Yamada K, Nabeshima T.
Biochem Res Internat. page： 681385 2011
-
Chronic restraint stress impairs neurogenesis and hippocampus-dependent fear memory in mice: possible involvement of a brain-specific transcription factor Npas4. Reviewed
Yun J, Koike H, Ibi D, Toth E, Mizoguchi H, Nitta A, Yoneyama M, Ogita K, Yoneda Y, Nabeshima T, Nagai T, Yamada K.
J Neurochem. Vol. 114 ( 6 ) page： 1840-1851 2010.9
-
Oral supplementation with Leu-Ile, a hydrophobic dipeptide, prevents the impairment of memory induced by amyloid beta in mice via restraining the hyperphosphorylation of extracellular signal-regulated kinase. Reviewed
Alkam T, Nitta A, Furukawa-Hibi Y, Niwa M, Mizoguchi H, Yamada K, Nabeshima T.
Behav Brain Res. Vol. 210 ( 2 ) page： 184-190 2010.7
-
Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. Reviewed
Katsuno M, Adachi H, Minamiyama M, Waza M, Doi H, Kondo N, Mizoguchi H, Nitta A, Yamada K, Banno H, Suzuki K, Tanaka F, Sobue G.
J Neurosci. Vol. 30 ( 16 ) page： 5702-5712 2010.4
-
Alterations of emotional and cognitive behaviors in matrix metalloproteinase-2 and -9-deficient mice. Reviewed
Mizoguchi H., Ibi D., Takuma K., Toth E., Sato J., Itohara S, Nabeshima T, Yamada K.
The Open Behav Sci J. Vol. 4 page： 19-25 2010.4
-
Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Reviewed
Ibi D, Nagai T, Koike H, Kitahara Y, Mizoguchi H, Niwa M, Jaaro-Peled H, Nitta A, Yoneda Y, Nabeshima T, Sawa A, Yamada K.
Vol. 206 ( 1 ) page： 32-37 2010.1
-
Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: Involvement of pallidotegmental neurons. Reviewed
Mizoguchi H, Arai S, Koike H, Ibi D, Kamei H, Nabeshima T, Kim HC, Takuma K, and Yamada K.
Psychopharmacology(Berl) Vol. 207 ( 2 ) page： 235-243 2009.12
-
Mice Deficient for Glucagon Gene-Derived Peptides Display Normoglycemia and Hyperplasia of Islet {alpha}-Cells But Not of Intestinal L-Cells. Reviewed
Hayashi Y, Yamamoto M, Mizoguchi H, Watanabe C, Ito R, Yamamoto S, Sun XY, and Murata Y.
Mol Endocrinol. Vol. 23 ( 12 ) page： 1990-1999 2009.12
-
Microglia activated with toll-like receptor 9 ligand CpG attenuate oligomeric amyloid β neurotoxicity in vitro and in vivo models of Alzheimer's disease. Reviewed
Doi Y, Mizuno T, Maki Y, Jin S, Mizoguchi H, Ikeyama M, Doi M, Michikawa M, Takeuchi H, and Suzumura A.
Am J Pathol. Vol. 175 ( 5 ) page： 2121-2132 2009.11
-
RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Reviewed
Takuma K, Fang F, Zhang W, Yan S, Fukuzaki E, Du H, Sosunov A, McKhann G, Funatsu Y, Nakamichi N, Nagai T, Mizoguchi H, Ibi D, Hori O, Ogawa S, Stern DM, Yamada K, Yan SS.
Proc Natl Acad Sci U S A. Vol. 106 ( 47 ) page： 20021-20026 2009.11
-
*Matrix metalloprotease-9 inhibition improves amyloid β-mediated cognitive impairment and neurotoxicity in mice. Reviewed
Mizoguchi H, Takuma K, Fukuzaki E, Ibi D, Someya E, Akazawa K, Alkam T, Tsunekawa H, Mouri A, Noda Y, Nabeshima T, and Yamada K.
J Pharmacol Exp Ther. Vol. 331 ( 1 ) page： 14-22 2009.10
-
Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood. Reviewed
Nakatani-Pawlak A, Yamaguchi K, Tatsumi Y, Mizoguchi H and Yoneda Y.
Biol Pharm Bull. Vol. 32 ( 9 ) page： 1576-1583 2009.9
-
Behavioral abnormality and pharmacologic response in social isolation-reared mice. Reviewed
Behav Brain Res. Vol. 202 ( 1 ) page： 114-121 2009.8
-
Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood. Reviewed
Ibi D, Nagai T, Kitahara Y, Mizoguchi H, Koike H, Shiraki A, Takuma K, Kamei H, Noda Y, Nitta A, Nabeshima T, Yoneda Y, and Yamada K.
Neurosci Res. Vol. 64 ( 3 ) page： 297-305 2009.7